SynthesisFrontiers in immunology2025

Risk factors for checkpoint inhibitor pneumonitis in lung cancer patients treated with immune checkpoint inhibitors: a systematic review and meta-analysis.

Xiaoqing Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.